Instructions for Diclofenac
Diclofenac
ATX code: M01AB05 (Diclofenac)
Active ingredient: diclofenac
Rec.INN registered by WHO
Drug form
Diclofenac
Table of Intestinal Soluble Coating, 50 mg: 20 pcs
reg. No. : P N011648/01 from 08.09.09 - Indefinitely
Form of release, packaging and composition of Diclofenac drug
a colorless or slightly yellowish transparent gel with a characteristic odor.
Intestinal-coated tablets 1 tab
sodium Diclofenac 50 mg
10 pcs - blisters (2) - cardboard packs.
Clinical-pharmacological group: NSAIDs Diclofenac
Pharmacotherapeutic group: NSAIDs
Pharmacological effect
NSAIDs, a derivative of phenylacetic acid. It has strong anti-inflammatory, analgesic and moderately antipyretic effects. The mechanism of action is related to inhibition of the activity of COX, a key enzyme of arachidonic acid metabolism that is a precursor to prostaglandins.
Dosing mode Diclofenac
The method of use and dosing regimen for a particular drug depend on its release form and other factors. The optimal dosing regimen is determined by the doctor. The dosage formula used should be carefully evaluated to match the specific drug indicated and the dosing schedule.
The dose is titrated to the patient, with the lowest effective dose recommended, and the shortest possible period of treatment.
- ICD-10 Code Indication
- H66 Suppurative and unspecified otitis media
- H92.0 Otalgia
- J02 Acute pharyngitis
- J03 Tonsillitis acute
- J31.2 Chronic pharyngitis
- J35.0 Chronic tonsillitis
- M05 Seropositive rheumatoid arthritis
- M08 Juvenile [juvenile] arthritis
- M10 Gout
- M13.9 Arthritis, unspecified
- M15 Polyarthrosis
- M19.9 Arthrosis, unspecified
- M25.5 Pain joint
- M42 Osteochondrosis of spine
- M45 Ankylosing spondylitis
- M47 Spondylosis
- M54 Dorsalgia
- M54.1 Radiculopathy
- M54.3 Ischias
- M54.4 Lumbago with sciatica
- M65 Synovitis and tenosynovitis
- M70 Soft tissue diseases related to stress, strain, and pressure
- M71 Other bursopathies
- M79.1 Myalgia
- M79.2 Neuralgia and neuritis, unspecified
- N70 Salpingitis and oophoritis
- N94.4 Primary dysmenorrhea
- N94.5 Secondary dysmenorrhoea
- R07.0 Sore throat
- R52.0 Acute pain
- R52.2 Other persistent pain (chronic)
- T14.3 Dislocation, sprain, and straining of capsule ligament system of joint of unspecified body region
Indications Diclofenac
Inflammatory and degenerative diseases of musculoskeletal system, including rheumatoid, juvenile, chronic arthritis; ankylosing spondylitis and other spondyloarthropathies; osteoarthritis; gouty arthritis; bursitis, tenosynovitis; vertebral pain syndrome (lumbago, sciatica, ossalgia, neuralgia, myalgia, arthralgia, radiculitis); post-traumatic postoperative pain syndrome accompanied by inflammation (eg, in dentistry and orthopedics); algodysmenorrhea; Pelvic inflammatory processes (including adnexitis); inflammatory diseases of ENT organs with severe pain syndrome (as part of complex therapy): pharyngitis, tonsillitis, otitis.
Isolated fever is not an indication for drug use Diclofenac
The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.
